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ABSTRACT Efficient major histocompatibility complex
class II gene expression requires conserved protein-binding
promoter elements, including X and Y elements. We affinity
purified an HLA-DRA Y-element (CCAAT)-binding protein
(YEBP) and used it to reconstitute Y-depleted HLA-DRA in
vitro transcription. This directly demonstrates a positive func-
tional role for YEBP in HLA-DRA transcription. The ability of
YEBP to regulate divergent CCAAT elements was also as-
sessed; YEBP was found to partially activate the thymidine
kinase promoter. This functional analysis of YEBP shows that
this protein plays an important role in the regulation of
multiple genes.
other CCAAT elements. Recent development of a human
B-cell in vitro transcription system (8, 24) makes possible the
direct functional analysis of MHC class II regulatory pro-
teins.
In this paper we describe the partial purification of one
human MHC class II Y-element (CCAAT)-binding protein
(YEBP) and we directly assess the ability of YEBP to
regulate DRA gene transcription. We also demonstrate that
YEBP can regulate transcription from another CCAAT-
containing promoter, the thymidine kinase (TK) gene of
herpes simplex virus (HSV). The implications ofthese results
will be discussed.
An understanding of major histocompatibility complex
(MHC) class II gene regulation is important for understanding
and modulating immune regulation (1, 2). Promoter elements
important in the inducible and basal expression of class II
MHC genes, including the V, W, X, Y, and octamer ele-
ments, have been defined by deletion and mutation analyses
(3-13). These elements bind multiple proteins as determined
by gel mobility shift analysis and by direct cloning from
expression libraries (14-16). Most pertinent to this study is
the class II box which is found in all MHC class II genes and
consists of the X [15-base-pair (bp)] and Y (8-bp) elements
separated by a spacer of 18-21 bp (see Fig. 1). The purpose
of this study is to analyze the function ofa Y-element-binding
protein (YEBP) in transcription of the MHC class II HLA-
DRA gene (called DRA hereafter).
The Y element contains a CCAAT box in reverse orien-
tation to the direction of transcription. Proteins bind to the
CCAAT sequence, and mutations within this element disrupt
in vitro protein binding and in vivo function (6, 14, 17, 18).
CCAAT-element-binding proteins all bind to a core
"CCAAT" sequence, with flanking bases determining the
binding heterogeneity of these proteins (17, 19, 20). Multiple
CCAAT-binding proteins have been described, including
CTF/NF1 (19), C/EBP (21), and CP1 and CP2 (20) among
others. Binding specificities of the CCAAT-binding proteins
CP1, CP2, and NF-1 (20) and NF-Y, NF-1, and C/EBP have
been compared (17). In particular, the murine MHC class II
Y-binding protein NF-Y was distinct from NF-1 and C/EBP
by differential competition in gel mobility shift analysis (17).
These comparisons demonstrate CCAAT-binding protein
heterogeneity.
Although Y-binding proteins have been characterized by
binding assays and described by limited biochemical analysis
(18, 22, 23), direct functional analysis of these Y-binding
proteins has not been described. Furthermore, it is not
known if the proteins that bind to Y can also regulate through
MATERIALS AND METHODS
Plasmids and Oligonucleotides. The 5'A-56(X+Y) plasmid,
which contains 109 bp of the wild-type DRA promoter
upstream of the bacterial chloramphenicol acetyltransferase
(CAT) reporter gene, the 5'A-56, the 5'A-56mutlX, 5'A-
56mutY, and 5'Arev(X+Y) plasmids were described (18).
The pDHF-210 plasmid contains 210 bp of the hamster
dihydrofolate reductase (DHFR) promoter upstream of the
CAT reporter gene (25). The plasmid TK71CAT, which
contains 200 bp of the HSV TK promoter, and pH-2KbA&15,
which contains base pairs -65 to +3 ofthe mouse MHC class
I H2Kb gene, were kindly provided by A. Baldwin (Univer-
sity of North Carolina).
Double-stranded competitors were prepared as described
(18). For competition, the sequences of the upper (5' to 3')
strand of the double-stranded oligonucleotides are Y,
TAAAAAGACTAACCGGTTTCT and Spl, GATCGGGG-
CGGGGC. X+Y (50 bp), X+spacer (36 bp), and Y+spacer
(33 bp) were as described previously (18).
Nuclear Extracts. Namalwa B-lymphoblastoid cells (from
R. Roeder, Rockefeller University) and BALB/c 3T3 cells
were used to prepare nuclear extracts, using a modification
(25) ofthe Dignam procedure (26) with the following addition.
Protease inhibitors at final concentrations of 2 mM 3,4-
dichloroisocoumarin, 2 mM 1,10-phenanthroline, and 0.4
mM E-64 (I-mix) (Pharmacia LKB) were added to buffers C
and D. The extract was frozen in aliquots at -70'C.
In Vitro Transcription Assays. Transcription reactions (25
,l final volume) were performed essentially as described (25).
Template DNA was linearized with Nco I for all plasmids,
except pDHF-210 plasmid, which was digested with Sca I, to
produce discrete-sized transcripts. An internal standard ra-
diolabeled 494-nucleotide Sp6 transcript (supplied by R.
Kole, University of North Carolina) was added to each
Abbreviations: MHC, major histocompatibility complex; YEBP,
Y-element-binding protein; TK, thymidine kinase; HSV, herpes
simplex virus; CAT, chloramphenicol acetyltransferase; DHFR,
dihydrofolate reductase; BSA, bovine serum albumin.
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sample to detect differences in recovery. Size markers were
an end-labeled 0.16-1.77-kilobase (kb) RNA ladder (BRL).
Transcription reactions were reconstituted with affinity-
purified YEBP (200 ng), AC100 buffer (see below), 3 jug of
bovine serum albumin (BSA) in AC100, a protein-containing
flow-through affinity column fraction, or 3 ug of unfraction-
ated Namalwa nuclear extract in AC100. Transcript produc-
tion was quantitated by densitometry of autoradiographs
using an LKB Ultrascan densitometer.
Affinity Purification of YEBP. Affinity columns were pre-
pared (27), using 50-bp X+Y oligonucleotides (18). Namalwa
nuclear extract was first fractionated by heparin-agarose
(Sigma) chromatography. YEBP activity, monitored by gel
mobility shift reactions with the X+Y probe, was eluted with
a linear gradient from HA100 [25 mM Tris HCl, pH 8/20%o
(vol/vol) glycerol/0.5 mM dithiothreitol/0.2 mM EDTA/100
mM KCl/I-mix] to HA500 (HA100 except 500 mM KCI) and
the-fractions were dialyzed against HA100. YEBP activity
was quantitated by scintillation counting of shifted bands and
free probe in the gel shift assay. YEBP-containing fractions
were chromatographed over an X+Y-affinity column twice,
and YEBP activity was eluted with a linear gradient ofAC100
(HA100/0.1% Nonidet P40) to AC2000 (2 M KCl). BSA (0.3
mg/ml) was added to the fractions before dialysis against
AC100. Aliquots were stored at -700C.
RESULTS
Accurate Transcription from a DRA Template in Vitro
Requires Both X and Y Elements. Nuclear extracts from the
Namalwa human B-cell line supplied factors necessary for
transcription from the MHC class II DRA promoter in vitro.
The template for transcription was the plasmid 5'A-56(X+Y),
which contains 109 bp of the wild-type DRA promoter (the
basal promoter) fused to the CAT reporter gene (Fig. 1) (18).
The plasmid was digested with Nco I, which cleaves in the
CAT reporter gene, resulting in a 595-base run-off transcript
(Fig. 2, lane 2). In contrast, no detectable transcript was
obtained from the 5'A-56 plasmid, which lacks the X and Y
elements (Fig. 2, lane 1).
Elements defined by transient transfection analysis do not
necessarily function in transcription systems in vitro (28, 29).
To determine whether these elements regulate transcription
in vitro, plasmids containing either mutated X element or
mutated Y element were analyzed (Fig. 1). Mutation of the X
element resulted in a 95% decrease in transcription as deter-
mined by densitometry scanning of autoradiographs (Fig. 2,
lane 3). Mutation of the Y element resulted in a 90% decrease
in transcription (Fig. 2, lane 4). The orientation of X and Y
elements must also be conserved in vitro, since a plasmid
with the X, spacer, and Y elements in reverse orientation,
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FIG. 2. Mutation of X or Y elements decreases DRA transcrip-
tion. In vitro transcription samples using wild-type or mutant tem-
plate DNA linearized with Nco I were electrophoresed on a dena-
turing 4% polyacrylamide gel. Correctly initiated DRA transcript is
595 nucleotides (upper arrow). Transcript level is quantitated relative
to a radiolabeled internal standard 494-nucleotide transcript (lower
arrow). Template plasmids used are indicated.
uct (Fig. 2, lane 5). These results parallel previous in vivo
findings (18).
Oligonucleotides Representing DRA Promoter Elements
Compete for DRA Transcription Factors in Vitro. Efficient
DRA transcription depends on intact X and Y elements,
which bind to proteins as shown by gel shift analysis (18).
This suggests that disrupting protein binding to these ele-
ments might disrupt transcription. To functionally deplete
transcription extracts ofX- and Y-binding proteins, an excess
of double-stranded oligonucleotides corresponding to the X
and Y elements was added to an in vitro transcription extract.
An alternative approach employing double-stranded oligo-
nucleotide-coupled Sepharose to physically deplete the spe-
cific DNA-binding proteins was tested, but it did not work
well because this manipulation significantly (more than 90%6)
reduced general transcription (N.J.Z.-L., unpublished obser-
vations).
In vitro DRA transcription from the 5'A-56(X+Y) DRA
template (Fig. 3, lanes 1 and 11) was specifically reduced by
the addition of excess competitor corresponding to the ele-
ments X (lanes 2-4), Y (lanes 5-7), or X+Y (lanes 8-10) in
a dose-dependent fashion. Higher amounts of competitor
resulted in transcription from incorrect initiation sites (lane
4). This observation is consistent with our previous S1
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FIG. 1. Schematic representation of the
DRA promoter and mutant plasmids. The
promoter elements X, Y, octamer, and
TATA are contained in 109 bp of the DRA
promoter. The 5'A-56 plasmid contains 56 bp
of the DRA promoter upstream of the CAT
gene. 5'A-56(X+Y) has the 50-bp X+Y oli-
gonucleotide inserted upstream of the oc-
tamer element into the 5'A-56 plasmid. 5'A-
56mutlX and 5'A-56mutY have the indicated
base substitutions in the X and Y elements,
respectively. 5'A-56rev(X+Y) has the 50-bp
X+Y oligonucleotide inserted in reverse ori-
entation into the 5'A-56 plasmid.
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that mutations in X or Y elements resulted in aberrant DRA
transcripts (18).
As a specificity control, we used a competitor correspond-
ing to the Spl element, which is not present in the DRA
promoter. It does not decrease DRA transcription (lanes
12-14) and actually reproducibly increases the level ofDRA
transcript. In addition, Y oligonucleotide does not compete
with transcription from an unrelated plasmid containing the
hamster DHFR promoter (25) at the same concentrations (see
Fig. 5B, lane 3).
Reconstitution of DRA Transcription with Affinity-Purified
YEBP. We next tested purified YEBP for its ability to
reconstitute the Y-depleted transcription system. YEBP was
enriched from Namalwa nuclear extracts by chromatography
on heparin-agarose, followed by two passages over an X+Y-
Sepharose column (Table 1). The resulting highly enriched
YEBP fraction was assayed for specificity by the gel mobility
shift assay (Fig. 4). The purified fraction had seven protein
bands by silver stain of an SDS/polyacrylamide gel (data not
shown). Efforts to elute and renature individual protein bands
alone and in combination resulted in loss of Y-element-
binding activity. Therefore, for further studies, the partially
purified YEBP affinity column fraction was used. YEBP
protein was purified 3400-fold with an increase in the specific
activity from 68 to 45,200 fmol of [32P]DNA bound specifi-
cally per mg of protein and an overall yield of 19% (Table 1).
This preparation was used for the reconstitution experiments
described below.
The amount of Y oligonucleotide competitor added to
functionally deplete the extract was titrated to achieve 50-
80% reduction in transcription. Utilizing suboptimal levels of
competitors was important to ensure that a positive or
negative effect of added YEBP in transcription would be
observed. Subsequently, afflinity-purified YEBP was added
to the functionally depleted extract. Purified YEBP protein
could reconstitute in vitro transcription (Fig. SA, lane 5). The
level of reconstitution averaged 49% (range 28% to 69% from
four experiments) as determined by densitometry. The ex-
perimental samples were quantitated relative to the level of
internal 494-nucleotide standard. In contrast, buffer alone
(lane 2) or a flow-through column fraction (lane 3) was unable
Table 1. Affinity purification of YEBP
Protein, Vol, Specific Purif., Yield,
Fraction mg ml activity* fold %
Nuclear extract 813 132 68 1 100
Heparin-agarose 113 96 515 7.2 %
First X+Y affinity 2.3 53 15,900 359 64
Second X+Y affinity 0.24 10 45,200 3400 19
*[12PIDNA bound specifically, fmol/mg of protein.
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FIG. 3. Specific oligonucleotide compe-
tition ofDRA transcription. Increasing quan-
tities (10- to 40-fold molar excess) of double-
stranded oligonucleotides corresponding to
the DRA X element (lanes 2-4), Y element
(lanes 5-7), X+Y elements (lanes 8-10), or
*''$ to the Spl element (lanes 12-14) were added
to in vitro transcription assays with the wild-
type DRA template, 5'A-56(X+Y). The level
of DRA transcript (upper arrow) was com-
pared between reactions with and without
added competitors, relative to an internal
standard radiolabeled 494-nucleotide tran-
script (lower arrow). Lanes 1-10 and lanes
11 12 13 14 11-14 were from different gels.
to reconstitute transcription. In fact, the added flow-through
column fraction inhibited DRA transcription. Addition of 3
pg of crude nuclear extract (lane 4) minimally reconstituted
DRA transcription (average of 5% in three experiments),
whereas addition of buffer containing 3 Mg of BSA had no
effect on the level ofDRA transcript (compare lanes 7 and 8).
To determine if the effect of YEBP on DRA transcription
was specific, similar experiments were done with a plasmid
containing the DHFR promoter. The DHFR promoter does
not contain any elements resembling the DRA Y element, and
Y competitor does not block DHFR transcription (Fig. SB,
lane 3). Addition of purified YEBP to the DHFR template in
the presence of excess Y competitor also had no effect on
DHFR transcription (lane 4). As a second level of control,
specific synthesis of DHFR transcripts (lanes 1 and 5) was
blocked with excess Spl competitor (lanes 2 and 6) (25).
However, addition of YEBP could not reconstitute the tran-
scription of this gene (Fig. SB, lane 8). Therefore, the
enriched YEBP reconstitutes DRA transcription in a specific
fashion.
Regulation of Other CCAAT-Element-Containing Promot-
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FIG. 4. Gel mobility shift analysis of highly enriched YEBP.
Samples of the highly enriched YEBP-containing fraction and a
32P-labeled DRA X+Y oligonucleotide were electrophoresed on a
nondenaturing 6% polyacrylamide gel. Shifted YEBP'oligonucleo-
tide complex (YEBP) and free oligonucleotide probe (F) are indi-
cated. Competitors (200-fold molar excess) were added to the gel
shift reaction mixture to assess the specificity ofYEBP. Competitors
used were none (lane 1), X+Y (lane 2), X+spacer (lane 3), Y+spacer
(lane 4), and a nonspecific competitor corresponding to base pairs
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Table 2. Comparison of CCAAT elements
Gene Sequence DRA identity Ref.
DRA (-67) TTGGC.AMICAGAA 14/14 5
HSV TK (-82)TICGCCAATGACAA 11/14 20
HSP70 (-70) IGAGCCAAICACCG 9/14 20
e-Globin (-80) IMACCAAIGACTT 9/14 30
H-2Kb (-51) AGAACCAAICAGTG 8/14 20
AdMLP (-76) TAAACCAATCACCT 8/14 20
The number listed to the left of each sequence indicates the
position of the first C of the CCAAT pentanucleotide relative to the
transcription initiation site. The core CCAAT sequence is double
underlined. Bases identical to the DRA CCAAT sequence are
underlined. HSP70, 70-kDa heat shock protein; AdMLP, adenovirus
major late promoter.
of transcripts from each of the promoters was inhibited with
increasing amounts of double-stranded Y oligonucleotide
2 3 4 5 6 7 8 (data not shown). The capacity of purified YEBP to recon-
stitute transcription from the above promoters was examined
by using the same strategy described for DRA (Fig. 5). Of all
m a} m the constructs tested, enriched YEBP could reconstitute
m > :: m >_ transcription only from the HSV TK promoter (Fig. 6, lane
- Y7Sp 6). The reconstitution was low but reproducible, averaging
9% (range 8% to 10%). Reactions reconstituted with buffer
____ If (lane 3), with protein-containing flow-through column frac-
7__ '4 tion (lane 4), or with unfractionated nuclear extract (lane 5)
did not reconstitute HSV TK expression. In contrast, YEBP
was unable to reconstitute DRA transcription from the MHC
class I promoter (Fig. 6, lanes 7-12) or from the other
promoters mentioned above (data not shown).
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FIG. 5. Specific reconstitution ofDRA transcription with purified
YEBP. (A) Transcription of DRA template (upper arrow) without
competitor (lanes 1 and 6) or with Y competitor (lanes 2-5, 7, and 8).
Transcription was reconstituted with AC100 buffer (Buffer) (lanes 2
and 7), with an affinity column fraction lacking YEBP (flow-through,
FT) (lane 3), with 3 pg of crude nuclear extract (Crude) (lane 4), with
3 pg of BSA (lane 8), or with 200 ng of highly enriched YEBP (lane
5). Lanes 1-5 and lanes 6-8 are from different experiments. DRA
transcript levels were quantitated relative to an internal standard
494-nucleotide transcript (lower arrow). (B) Transcription of control
DHFR template without competitor (lanes 1 and 5), with Spl
competitor (lanes 2 and 6-8), or with Y competitor (lanes 3 and 4).
Transcription was reconstituted with AC100 buffer (lanes 3 and 7) or
with YEBP (lanes 4 and 8). Double upper arrows designate major and
minor start sites. Note that the 494-nucleotide internal standard
shown in lanes 1-4 (lower arrow) is not seen in lanes 5-8, but it was
observed on a longer exposure (not shown).
II genes is a member of the CCAAT family of promoter
elements. Gel-shift analyses suggest that the binding of
CCAAT-binding proteins to target DNA is influenced by the
sequence flanking the CCAAT sequence (17, 19). The pur-
pose of the following experiments was to determine ifYEBP
could reconstitute transcription from other CCAAT element-
containing templates. Plasmids with the following CCAAT-
containing promoters were used: human e-globin, 70-kDa
human heat shock protein, HSV TK, adenovirus major late
promoter, and MHC class I H-2K genes (Table 2). All of these
promoters contain a CCAAT element needed for transcrip-
tion, but with variable flanking sequence. Homology to the
DRA CCAAT sequence is shown (Table 2).
We addressed the capacities of the DRA Y oligonucleotide
to compete with transcription and of enriched YEBP to
reconstitute transcription from these different promoters.
Except for adenovirus major late promoter, in vitro synthesis
Several X- and Y-element-binding proteins have been iden-
tified by gel mobility shift analysis and by cloning, but the role
of these specific proteins in MHC class II transcription has
not yet been identified. The type of in vitro transcription
analysis described in this paper enables the direct functional
analysis of purified or cloned proteins alone or in combina-
tion. Only after such functional analysis will we begin to
understand the requisite protein-DNA and protein-protein
interactions necessary for accurate and efficient MHC class
II gene transcription.
The experiments described here were designed to ascertain
the role of YEBP, a DRA Y (CCAAT)-element-binding
protein, in MHC class II gene transcription. YEBP is likely
similar to murine NF-Y (6) and to the Y proteins described by
other laboratories (11, 23). Results of in vitro transcription
analysis (Fig. 2) confirmed previous in vivo results that the X
and Y elements are required for efficient DRA transcription
(18). In addition, functional depletion of YEBP activity
decreased the level of specific DRA transcript (Fig. 3). Most
importantly, we directly demonstrated a positive functional
role for YEBP in DRA transcription. We know of no earlier
direct functional analysis of any purified or cloned MHC
class II regulatory protein.
YEBP is of broad importance because it binds to aCCAAT
element. CCAAT-element-binding proteins are a family of
proteins; however, their functional specificities in gene
expression have not been determined. Here we examined
whether YEBP could function in the transcription of other
CCAAT-containing promoters. These promoters varied in
the extent of similarity in the regions immediately adjacent to
the CCAAT sequence (Table 2). In addition to the DRA
promoter, YEBP could partially reconstitute transcription
from the HSV TK promoter. Analysis of the murine MHC
class II Ea binding protein NF-Y had demonstrated that its
binding activity was partially blocked with a HSV TK
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results we observed, since YEBP partially reconstituted
Y-depleted transcription from the TK promoter (Fig. 6) but
could more fully reconstitute DRA transcription (Fig. 5A).
Interestingly, both MHC class and TK genes are cell cycle
regulated (31-33). YEBP also has a role in the cell cycle
regulation of gene expression (N.J.Z.-L., unpublished data).
There are several possible reasons why DRA Y competitor
could block transcription from several CCAAT-containing
promoters but YEBP could not reconstitute transcription
from most of these promoters. One explanation is that
proteins that normally bind to other CCAAT elements cross-
react with the DRA Y (CCAAT) competitors and that this
binding is not physiologically relevant. Another possibility is
that the different CCAAT-binding proteins contain a common
DNA-binding domain but different activation domains. This
second possibility seems more likely, since YEBP could bind
to the CCAAT elements from DRA, MHC class I H62Kbt
HSV TK, and adenovirus major late promoter by the gel
mobility shift assay (data not shown). This suggests that
although YEBP could bind to each of these CCAAT ele-
ments, transcription could be activated from only a subset of
them. Although we have not directly addressed whether
YEBP added to our depleted system acts indirectly by
decreasing the effective level of competitors, we feel that this
interpretation is unlikely. If YEBP were acting in this man-
ner, one would have expected YEBP to increase the tran-
scription from each of the CCAAT-containing promoters
tested, since YEBP is capable of binding to the various
promoters. This was not observed.
In this report we described the partial purification of
YEBP, a human MHC class Y-element (CCAAT)-binding
protein. Second, and most importantly, we directly demon-
strated that YEBP positively regulates DRA transcription as
well as transcription from another CCAAT-element-
containing promoter. Thus, YEBP could have a broad role in
the regulation of multiple genes.
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